David Kroll
Concepts (447)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Topoisomerases, Type II | 11 | 2005 | 43 | 1.390 |
Why?
| Antineoplastic Agents, Phytogenic | 16 | 2012 | 187 | 1.140 |
Why?
| Plant Extracts | 10 | 2010 | 199 | 0.820 |
Why?
| Silymarin | 10 | 2016 | 199 | 0.750 |
Why?
| Phytotherapy | 8 | 2010 | 79 | 0.680 |
Why?
| Isoenzymes | 5 | 2001 | 302 | 0.620 |
Why?
| Plants, Medicinal | 7 | 2009 | 22 | 0.540 |
Why?
| Antineoplastic Agents | 13 | 2016 | 2061 | 0.530 |
Why?
| Prostatic Neoplasms | 10 | 2016 | 1016 | 0.500 |
Why?
| Topoisomerase II Inhibitors | 3 | 2005 | 24 | 0.430 |
Why?
| Flavonolignans | 4 | 2009 | 10 | 0.420 |
Why?
| Enzyme Inhibitors | 4 | 2012 | 827 | 0.410 |
Why?
| Camptothecin | 4 | 2009 | 109 | 0.410 |
Why?
| Hypocreales | 4 | 2013 | 8 | 0.400 |
Why?
| Drug Interactions | 5 | 2010 | 394 | 0.390 |
Why?
| Etoposide | 3 | 2001 | 148 | 0.380 |
Why?
| Hypericum | 2 | 2001 | 2 | 0.380 |
Why?
| Drug Screening Assays, Antitumor | 16 | 2013 | 195 | 0.370 |
Why?
| Tumor Cells, Cultured | 9 | 2006 | 940 | 0.360 |
Why?
| Transcriptional Activation | 4 | 1997 | 366 | 0.350 |
Why?
| DNA | 9 | 2001 | 1400 | 0.300 |
Why?
| Molecular Structure | 15 | 2013 | 482 | 0.290 |
Why?
| Paclitaxel | 2 | 2009 | 217 | 0.270 |
Why?
| Anti-Bacterial Agents | 6 | 2013 | 1717 | 0.270 |
Why?
| Biological Products | 3 | 2012 | 202 | 0.260 |
Why?
| Cell Line, Tumor | 19 | 2016 | 3215 | 0.260 |
Why?
| Promoter Regions, Genetic | 4 | 2005 | 1207 | 0.250 |
Why?
| Terminology as Topic | 1 | 2007 | 204 | 0.250 |
Why?
| Plant Proteins | 2 | 2004 | 89 | 0.230 |
Why?
| Antigens, Neoplasm | 6 | 2005 | 309 | 0.220 |
Why?
| DNA-Binding Proteins | 6 | 2005 | 1443 | 0.220 |
Why?
| Colchicum | 3 | 2010 | 3 | 0.210 |
Why?
| Butyrates | 2 | 2001 | 56 | 0.210 |
Why?
| Peptaibols | 2 | 2013 | 2 | 0.210 |
Why?
| Terphenyl Compounds | 2 | 2013 | 4 | 0.200 |
Why?
| Indole Alkaloids | 2 | 2012 | 8 | 0.200 |
Why?
| Sesquiterpenes | 2 | 2013 | 53 | 0.200 |
Why?
| Transfection | 5 | 2000 | 911 | 0.190 |
Why?
| Antifungal Agents | 2 | 2013 | 129 | 0.190 |
Why?
| Herbal Medicine | 1 | 2001 | 5 | 0.190 |
Why?
| Perylene | 1 | 2001 | 9 | 0.190 |
Why?
| Terpenes | 1 | 2001 | 24 | 0.190 |
Why?
| Mixed Function Oxygenases | 1 | 2001 | 41 | 0.190 |
Why?
| Benzene | 1 | 2001 | 15 | 0.190 |
Why?
| Thylakoids | 1 | 2001 | 4 | 0.180 |
Why?
| Drug Carriers | 3 | 1998 | 118 | 0.180 |
Why?
| Aryl Hydrocarbon Hydroxylases | 2 | 2012 | 48 | 0.180 |
Why?
| Hemostasis | 1 | 2001 | 79 | 0.180 |
Why?
| Genes, Plant | 1 | 2001 | 46 | 0.180 |
Why?
| Biomedical Research | 1 | 2007 | 638 | 0.180 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2001 | 151 | 0.180 |
Why?
| Antioxidants | 4 | 2016 | 559 | 0.180 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 287 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 7 | 2012 | 2012 | 0.170 |
Why?
| Arabidopsis Proteins | 1 | 2001 | 68 | 0.170 |
Why?
| NF-kappa B | 4 | 2012 | 653 | 0.170 |
Why?
| Liposomes | 2 | 1998 | 168 | 0.170 |
Why?
| Arabidopsis | 1 | 2001 | 85 | 0.170 |
Why?
| Dietary Supplements | 1 | 2004 | 534 | 0.170 |
Why?
| Neoplasms | 4 | 2009 | 2470 | 0.170 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2001 | 209 | 0.170 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 431 | 0.160 |
Why?
| Ericales | 1 | 1999 | 2 | 0.160 |
Why?
| Diterpenes | 3 | 2009 | 32 | 0.160 |
Why?
| Cell Cycle Proteins | 3 | 2008 | 586 | 0.160 |
Why?
| Theophylline | 1 | 1999 | 68 | 0.160 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 8 | 2013 | 257 | 0.150 |
Why?
| Magnoliopsida | 1 | 1998 | 28 | 0.150 |
Why?
| Humans | 55 | 2016 | 129650 | 0.150 |
Why?
| Annonaceae | 2 | 2009 | 4 | 0.150 |
Why?
| Receptors, Androgen | 2 | 2010 | 147 | 0.150 |
Why?
| beta-Galactosidase | 1 | 1997 | 77 | 0.140 |
Why?
| Bronchodilator Agents | 1 | 1999 | 243 | 0.140 |
Why?
| Cloning, Molecular | 2 | 2001 | 524 | 0.140 |
Why?
| Nuclear Proteins | 3 | 2007 | 663 | 0.140 |
Why?
| Enhancer of Zeste Homolog 2 Protein | 1 | 2016 | 41 | 0.130 |
Why?
| Practice Guidelines as Topic | 1 | 2004 | 1501 | 0.130 |
Why?
| Transcription Factors | 5 | 2016 | 1651 | 0.130 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2016 | 63 | 0.130 |
Why?
| Colchicine | 2 | 2006 | 24 | 0.120 |
Why?
| Fungi | 3 | 2011 | 136 | 0.120 |
Why?
| Cyclic AMP Response Element-Binding Protein | 2 | 1993 | 141 | 0.120 |
Why?
| Leukemia, Promyelocytic, Acute | 1 | 1995 | 12 | 0.120 |
Why?
| Plasmids | 2 | 1993 | 358 | 0.120 |
Why?
| HeLa Cells | 5 | 1997 | 608 | 0.120 |
Why?
| HL-60 Cells | 3 | 2001 | 34 | 0.120 |
Why?
| Anthracenes | 2 | 2007 | 31 | 0.120 |
Why?
| Cell Cycle | 3 | 2007 | 592 | 0.120 |
Why?
| COS Cells | 4 | 2000 | 185 | 0.120 |
Why?
| Membrane Proteins | 1 | 2001 | 1119 | 0.110 |
Why?
| Lipids | 1 | 1998 | 625 | 0.110 |
Why?
| Gene Expression | 2 | 2005 | 1472 | 0.110 |
Why?
| Antiviral Agents | 2 | 2012 | 712 | 0.110 |
Why?
| Trans-Activators | 1 | 1997 | 388 | 0.110 |
Why?
| Microbial Sensitivity Tests | 6 | 2013 | 352 | 0.110 |
Why?
| Trichothecenes | 2 | 2011 | 4 | 0.110 |
Why?
| Isocoumarins | 1 | 2013 | 1 | 0.110 |
Why?
| Molecular Sequence Data | 7 | 2001 | 2832 | 0.110 |
Why?
| Recombinant Fusion Proteins | 2 | 1993 | 643 | 0.110 |
Why?
| Pyrrolidinones | 1 | 2013 | 29 | 0.110 |
Why?
| Proto-Oncogene Proteins | 1 | 1997 | 638 | 0.100 |
Why?
| Aldehydes | 3 | 1999 | 143 | 0.100 |
Why?
| Phosphodiesterase 4 Inhibitors | 1 | 2013 | 4 | 0.100 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2013 | 9 | 0.100 |
Why?
| Apoptosis | 4 | 2010 | 2503 | 0.100 |
Why?
| Ascomycota | 1 | 2013 | 31 | 0.100 |
Why?
| Structure-Activity Relationship | 5 | 2012 | 548 | 0.100 |
Why?
| Drug Stability | 3 | 2009 | 159 | 0.100 |
Why?
| Herb-Drug Interactions | 2 | 2009 | 4 | 0.100 |
Why?
| Benzoquinones | 1 | 2013 | 48 | 0.100 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1356 | 0.100 |
Why?
| Anthelmintics | 1 | 2012 | 10 | 0.100 |
Why?
| Disulfides | 1 | 2012 | 97 | 0.100 |
Why?
| Monocytes | 1 | 1995 | 551 | 0.100 |
Why?
| Xanthones | 1 | 2011 | 4 | 0.100 |
Why?
| Anthraquinones | 1 | 2011 | 10 | 0.100 |
Why?
| Drug Antagonism | 2 | 2001 | 10 | 0.090 |
Why?
| Depsipeptides | 1 | 2011 | 13 | 0.090 |
Why?
| Cyanobacteria | 1 | 2012 | 55 | 0.090 |
Why?
| Zearalenone | 1 | 2011 | 2 | 0.090 |
Why?
| Cyclin-Dependent Kinases | 3 | 2008 | 130 | 0.090 |
Why?
| Hepacivirus | 1 | 2012 | 235 | 0.090 |
Why?
| Drug Discovery | 1 | 2012 | 131 | 0.090 |
Why?
| Macrocyclic Compounds | 1 | 2010 | 9 | 0.090 |
Why?
| Lactones | 1 | 2011 | 58 | 0.090 |
Why?
| Drug Evaluation, Preclinical | 2 | 2010 | 171 | 0.090 |
Why?
| Piperazines | 1 | 2012 | 342 | 0.080 |
Why?
| Melanoma, Experimental | 1 | 1990 | 108 | 0.080 |
Why?
| Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 330 | 0.080 |
Why?
| Base Sequence | 6 | 1999 | 2142 | 0.080 |
Why?
| Leukemia | 2 | 2001 | 230 | 0.080 |
Why?
| Animals | 20 | 2012 | 35361 | 0.080 |
Why?
| Ginkgo biloba | 1 | 2009 | 6 | 0.080 |
Why?
| Recombinant Proteins | 4 | 2009 | 1304 | 0.080 |
Why?
| Amino Acid Sequence | 4 | 2001 | 2058 | 0.080 |
Why?
| Acclimatization | 1 | 1990 | 164 | 0.080 |
Why?
| Plant Preparations | 1 | 2009 | 32 | 0.080 |
Why?
| Echium | 1 | 2008 | 1 | 0.080 |
Why?
| Pyrrolizidine Alkaloids | 1 | 2008 | 7 | 0.080 |
Why?
| Warfarin | 1 | 2009 | 147 | 0.080 |
Why?
| Glutathione Transferase | 2 | 1999 | 101 | 0.080 |
Why?
| Staphylococcus aureus | 1 | 2013 | 438 | 0.080 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 2010 | 132 | 0.070 |
Why?
| Mercuric Chloride | 1 | 1988 | 2 | 0.070 |
Why?
| Prostate-Specific Antigen | 2 | 2008 | 162 | 0.070 |
Why?
| Epoxide Hydrolases | 1 | 1988 | 13 | 0.070 |
Why?
| Microsomes | 1 | 1988 | 35 | 0.070 |
Why?
| Protective Agents | 1 | 2008 | 39 | 0.070 |
Why?
| ErbB Receptors | 2 | 2012 | 607 | 0.070 |
Why?
| Fatty Acids, Monounsaturated | 2 | 1998 | 52 | 0.070 |
Why?
| Quaternary Ammonium Compounds | 2 | 1998 | 53 | 0.070 |
Why?
| Hot Temperature | 1 | 1990 | 370 | 0.070 |
Why?
| Immunoconjugates | 1 | 2009 | 103 | 0.070 |
Why?
| Hepatocytes | 1 | 2009 | 216 | 0.070 |
Why?
| Simaroubaceae | 1 | 2007 | 1 | 0.070 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 64 | 0.070 |
Why?
| Phosphorylation | 5 | 2016 | 1713 | 0.070 |
Why?
| Pharmacokinetics | 1 | 2007 | 29 | 0.070 |
Why?
| Monosaccharides | 1 | 2007 | 12 | 0.070 |
Why?
| Herpesvirus 8, Human | 1 | 2007 | 60 | 0.070 |
Why?
| Dendrimers | 1 | 2006 | 13 | 0.070 |
Why?
| Anti-Infective Agents | 1 | 2009 | 248 | 0.070 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 2012 | 539 | 0.070 |
Why?
| DNA, Neoplasm | 2 | 2001 | 159 | 0.070 |
Why?
| Blotting, Western | 5 | 2008 | 1205 | 0.070 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 278 | 0.070 |
Why?
| Genes | 1 | 1987 | 226 | 0.070 |
Why?
| Antibodies, Monoclonal | 2 | 2009 | 1367 | 0.070 |
Why?
| Anticarcinogenic Agents | 1 | 2007 | 77 | 0.060 |
Why?
| Flavones | 1 | 2006 | 10 | 0.060 |
Why?
| Calendula | 1 | 2006 | 1 | 0.060 |
Why?
| Case Management | 1 | 2006 | 64 | 0.060 |
Why?
| Candida albicans | 3 | 2013 | 53 | 0.060 |
Why?
| Patient Dropouts | 1 | 2006 | 64 | 0.060 |
Why?
| Heat-Shock Proteins | 1 | 1987 | 136 | 0.060 |
Why?
| Microsomes, Liver | 3 | 2012 | 87 | 0.060 |
Why?
| Purines | 1 | 2007 | 172 | 0.060 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 359 | 0.060 |
Why?
| Models, Biological | 3 | 2008 | 1722 | 0.060 |
Why?
| Chromatography, Affinity | 2 | 1997 | 83 | 0.060 |
Why?
| Genetic Variation | 1 | 1990 | 937 | 0.060 |
Why?
| Asteraceae | 1 | 2005 | 17 | 0.060 |
Why?
| Cell Growth Processes | 1 | 2005 | 52 | 0.060 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2005 | 38 | 0.060 |
Why?
| Protein Binding | 3 | 2001 | 2121 | 0.060 |
Why?
| In Vitro Techniques | 3 | 2009 | 1085 | 0.060 |
Why?
| Alkaloids | 1 | 2005 | 28 | 0.060 |
Why?
| Transcription, Genetic | 2 | 1993 | 1418 | 0.060 |
Why?
| Hypersensitivity, Delayed | 1 | 2004 | 28 | 0.060 |
Why?
| Anticoagulants | 1 | 2009 | 637 | 0.060 |
Why?
| Diospyros | 1 | 2004 | 1 | 0.060 |
Why?
| Clinical Trials as Topic | 2 | 2006 | 1004 | 0.060 |
Why?
| Societies, Pharmaceutical | 1 | 2004 | 21 | 0.060 |
Why?
| Liver | 2 | 2007 | 1839 | 0.060 |
Why?
| Naphthoquinones | 1 | 2004 | 19 | 0.060 |
Why?
| Methylation | 2 | 2016 | 230 | 0.060 |
Why?
| Taxus | 1 | 2004 | 1 | 0.060 |
Why?
| Camptotheca | 1 | 2004 | 1 | 0.060 |
Why?
| Topoisomerase I Inhibitors | 1 | 2004 | 16 | 0.060 |
Why?
| Carcinoma | 1 | 2006 | 217 | 0.060 |
Why?
| Pharmaceutical Services | 1 | 2004 | 81 | 0.050 |
Why?
| Deoxycytidine | 1 | 2004 | 165 | 0.050 |
Why?
| Cell Survival | 4 | 2012 | 1086 | 0.050 |
Why?
| Leucine Zippers | 2 | 1993 | 17 | 0.050 |
Why?
| Stereoisomerism | 3 | 2009 | 99 | 0.050 |
Why?
| Proteins | 2 | 2000 | 942 | 0.050 |
Why?
| History, 20th Century | 1 | 2004 | 291 | 0.050 |
Why?
| Patient Selection | 1 | 2006 | 663 | 0.050 |
Why?
| Patient Compliance | 1 | 2006 | 565 | 0.050 |
Why?
| Cell Proliferation | 4 | 2012 | 2391 | 0.050 |
Why?
| Male | 14 | 2016 | 63681 | 0.050 |
Why?
| Phloroglucinol | 1 | 2001 | 1 | 0.050 |
Why?
| Membrane Potential, Mitochondrial | 2 | 2012 | 68 | 0.050 |
Why?
| Bridged Bicyclo Compounds | 1 | 2001 | 11 | 0.050 |
Why?
| DNA Fragmentation | 1 | 2001 | 44 | 0.050 |
Why?
| Cytochrome P-450 CYP2C9 | 2 | 2012 | 20 | 0.050 |
Why?
| Evidence-Based Medicine | 1 | 2006 | 718 | 0.050 |
Why?
| Plastids | 1 | 2001 | 2 | 0.050 |
Why?
| Eubacterium | 1 | 2001 | 3 | 0.050 |
Why?
| Peptide Fragments | 2 | 1997 | 692 | 0.050 |
Why?
| Spectrophotometry, Ultraviolet | 2 | 2011 | 84 | 0.040 |
Why?
| Cytochrome P-450 CYP3A | 1 | 2001 | 87 | 0.040 |
Why?
| Cell Nucleus | 3 | 2010 | 582 | 0.040 |
Why?
| Carcinogens | 1 | 2001 | 110 | 0.040 |
Why?
| DNA, Single-Stranded | 2 | 1993 | 114 | 0.040 |
Why?
| Escherichia coli | 3 | 1993 | 774 | 0.040 |
Why?
| Catalysis | 1 | 2001 | 310 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 1 | 2001 | 372 | 0.040 |
Why?
| Photosynthesis | 1 | 2001 | 99 | 0.040 |
Why?
| Kidney | 1 | 1988 | 1385 | 0.040 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2000 | 73 | 0.040 |
Why?
| Family Practice | 1 | 2004 | 455 | 0.040 |
Why?
| Pharmacogenetics | 1 | 2001 | 175 | 0.040 |
Why?
| Detergents | 1 | 2000 | 44 | 0.040 |
Why?
| Biocompatible Materials | 2 | 2006 | 395 | 0.040 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 221 | 0.040 |
Why?
| Glycosides | 2 | 2013 | 37 | 0.040 |
Why?
| Carcinoma, Hepatocellular | 2 | 1999 | 272 | 0.040 |
Why?
| Neoplasm Proteins | 2 | 2016 | 424 | 0.040 |
Why?
| Serine Endopeptidases | 1 | 2000 | 118 | 0.040 |
Why?
| Esters | 1 | 2000 | 74 | 0.040 |
Why?
| Patient Education as Topic | 1 | 2004 | 743 | 0.040 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2011 | 148 | 0.040 |
Why?
| DNA Damage | 1 | 2001 | 384 | 0.040 |
Why?
| Cation Exchange Resins | 1 | 1998 | 7 | 0.040 |
Why?
| Mass Screening | 1 | 2006 | 1149 | 0.040 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2011 | 179 | 0.040 |
Why?
| Response Elements | 1 | 1999 | 90 | 0.040 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 87 | 0.040 |
Why?
| DNA Replication | 2 | 1997 | 228 | 0.040 |
Why?
| Freezing | 1 | 1998 | 86 | 0.040 |
Why?
| Thymidine | 2 | 1995 | 59 | 0.040 |
Why?
| Saccharomyces cerevisiae | 3 | 2009 | 532 | 0.040 |
Why?
| Gentamicins | 1 | 1998 | 54 | 0.040 |
Why?
| Arginine | 1 | 2000 | 265 | 0.040 |
Why?
| Polyesters | 1 | 1998 | 72 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor Proteins | 2 | 2008 | 7 | 0.040 |
Why?
| Cell Division | 2 | 1997 | 797 | 0.040 |
Why?
| Trehalose | 1 | 1997 | 30 | 0.040 |
Why?
| Drug Costs | 1 | 1998 | 100 | 0.040 |
Why?
| Malondialdehyde | 1 | 1997 | 28 | 0.040 |
Why?
| Plant Bark | 2 | 2009 | 11 | 0.040 |
Why?
| Scattering, Radiation | 1 | 1997 | 100 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 1997 | 74 | 0.040 |
Why?
| Enzyme Stability | 1 | 1997 | 69 | 0.040 |
Why?
| Aspergillus niger | 2 | 2009 | 9 | 0.040 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 37 | 0.040 |
Why?
| Indonesia | 2 | 2009 | 21 | 0.040 |
Why?
| Sucrose | 1 | 1997 | 99 | 0.030 |
Why?
| Freeze Drying | 1 | 1997 | 82 | 0.030 |
Why?
| Proto-Oncogene Proteins c-myb | 1 | 1997 | 10 | 0.030 |
Why?
| Dimerization | 1 | 1997 | 192 | 0.030 |
Why?
| Histone Deacetylase 2 | 1 | 2016 | 10 | 0.030 |
Why?
| Lipid Peroxidation | 1 | 1997 | 151 | 0.030 |
Why?
| Signal Transduction | 1 | 2010 | 4925 | 0.030 |
Why?
| Histone Deacetylase 1 | 1 | 2016 | 24 | 0.030 |
Why?
| Protein Conformation | 2 | 1997 | 859 | 0.030 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 32 | 0.030 |
Why?
| Binding Sites | 2 | 1997 | 1252 | 0.030 |
Why?
| Sequence Deletion | 1 | 1997 | 179 | 0.030 |
Why?
| Enzyme Activation | 3 | 2007 | 811 | 0.030 |
Why?
| Cytoplasm | 2 | 2008 | 263 | 0.030 |
Why?
| Proto-Oncogene Proteins c-jun | 2 | 1993 | 52 | 0.030 |
Why?
| KB Cells | 2 | 2007 | 4 | 0.030 |
Why?
| Precipitin Tests | 2 | 1997 | 94 | 0.030 |
Why?
| Breast Neoplasms | 2 | 2006 | 2142 | 0.030 |
Why?
| Jordan | 2 | 2006 | 3 | 0.030 |
Why?
| Artemia | 2 | 2006 | 8 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 331 | 0.030 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1565 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 2 | 1993 | 174 | 0.030 |
Why?
| Butyric Acid | 1 | 1995 | 7 | 0.030 |
Why?
| Drug Delivery Systems | 1 | 1998 | 336 | 0.030 |
Why?
| Time Factors | 3 | 2008 | 6556 | 0.030 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1995 | 149 | 0.030 |
Why?
| Light | 1 | 1997 | 360 | 0.030 |
Why?
| United States | 2 | 2004 | 13903 | 0.030 |
Why?
| Genes, Reporter | 1 | 1995 | 267 | 0.030 |
Why?
| Kinetics | 1 | 1997 | 1642 | 0.030 |
Why?
| Female | 8 | 2013 | 68776 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 1997 | 1033 | 0.030 |
Why?
| Bacteriophage T7 | 1 | 1993 | 5 | 0.030 |
Why?
| DNA, Recombinant | 1 | 1993 | 46 | 0.030 |
Why?
| Protein Sorting Signals | 1 | 1993 | 19 | 0.030 |
Why?
| Glioblastoma | 2 | 2007 | 326 | 0.030 |
Why?
| Adenovirus E1A Proteins | 1 | 1993 | 11 | 0.030 |
Why?
| DNA, Superhelical | 1 | 1993 | 11 | 0.030 |
Why?
| Kidney Tubules | 1 | 1994 | 114 | 0.030 |
Why?
| Mice | 4 | 2012 | 16937 | 0.030 |
Why?
| Nickel | 1 | 1993 | 54 | 0.030 |
Why?
| Haemonchus | 1 | 2012 | 1 | 0.030 |
Why?
| Depression | 1 | 2001 | 1307 | 0.020 |
Why?
| Rats | 4 | 1999 | 5500 | 0.020 |
Why?
| Phenotype | 1 | 2001 | 3076 | 0.020 |
Why?
| Glucose | 1 | 1997 | 1003 | 0.020 |
Why?
| Epigenesis, Genetic | 1 | 2016 | 613 | 0.020 |
Why?
| Optical Rotation | 1 | 2011 | 2 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 1 | 1993 | 361 | 0.020 |
Why?
| Antibiotics, Antineoplastic | 1 | 2012 | 123 | 0.020 |
Why?
| Spectrophotometry, Infrared | 1 | 2011 | 54 | 0.020 |
Why?
| Histones | 1 | 2016 | 588 | 0.020 |
Why?
| Hydroxybenzoates | 1 | 2011 | 10 | 0.020 |
Why?
| Resorcinols | 1 | 2011 | 5 | 0.020 |
Why?
| Crystallography, X-Ray | 1 | 2013 | 436 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 1994 | 457 | 0.020 |
Why?
| Blood Proteins | 1 | 1993 | 242 | 0.020 |
Why?
| Epitopes | 1 | 1993 | 470 | 0.020 |
Why?
| RNA, Messenger | 1 | 1998 | 2708 | 0.020 |
Why?
| Daunorubicin | 1 | 1990 | 26 | 0.020 |
Why?
| Caspase 8 | 1 | 2010 | 48 | 0.020 |
Why?
| Gene Expression Regulation | 2 | 1993 | 2548 | 0.020 |
Why?
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 29 | 0.020 |
Why?
| Protein Kinases | 1 | 1992 | 318 | 0.020 |
Why?
| Drug Tolerance | 1 | 1990 | 90 | 0.020 |
Why?
| Transcription Factor RelA | 1 | 2010 | 81 | 0.020 |
Why?
| Phosphates | 1 | 1991 | 180 | 0.020 |
Why?
| Aporphines | 1 | 2009 | 1 | 0.020 |
Why?
| Micrococcus luteus | 1 | 2009 | 3 | 0.020 |
Why?
| Hydroxylation | 1 | 2009 | 42 | 0.020 |
Why?
| Liver Function Tests | 1 | 2010 | 112 | 0.020 |
Why?
| Placebos | 1 | 2010 | 201 | 0.020 |
Why?
| Spectrum Analysis | 1 | 2010 | 89 | 0.020 |
Why?
| Indoles | 1 | 2012 | 387 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2012 | 345 | 0.020 |
Why?
| Inhibitory Concentration 50 | 1 | 2009 | 86 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2011 | 582 | 0.020 |
Why?
| Antibody Specificity | 1 | 2009 | 184 | 0.020 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 52 | 0.020 |
Why?
| Mycobacterium tuberculosis | 1 | 2012 | 308 | 0.020 |
Why?
| Acrolein | 2 | 1999 | 23 | 0.020 |
Why?
| Doxorubicin | 1 | 1990 | 325 | 0.020 |
Why?
| Cell Line | 2 | 1994 | 2781 | 0.020 |
Why?
| cdc25 Phosphatases | 1 | 2008 | 15 | 0.020 |
Why?
| Isomerism | 1 | 2008 | 53 | 0.020 |
Why?
| Bacteria | 2 | 2005 | 821 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2008 | 192 | 0.020 |
Why?
| Microcirculation | 1 | 2008 | 145 | 0.020 |
Why?
| Drug Design | 1 | 2009 | 156 | 0.020 |
Why?
| Mycobacterium | 1 | 2009 | 106 | 0.020 |
Why?
| Metallothionein | 1 | 1988 | 25 | 0.020 |
Why?
| Molecular Conformation | 1 | 2008 | 144 | 0.020 |
Why?
| Cyclins | 1 | 2008 | 89 | 0.020 |
Why?
| Enzyme Induction | 1 | 1988 | 90 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1988 | 368 | 0.020 |
Why?
| Peptides | 1 | 2013 | 925 | 0.020 |
Why?
| Leukemia P388 | 1 | 2007 | 7 | 0.020 |
Why?
| Dominican Republic | 1 | 2007 | 23 | 0.020 |
Why?
| Rats, Inbred F344 | 1 | 1988 | 257 | 0.020 |
Why?
| Cells, Cultured | 3 | 1994 | 4083 | 0.020 |
Why?
| Amino Acids | 1 | 1991 | 485 | 0.020 |
Why?
| Cell Differentiation | 1 | 1995 | 1902 | 0.020 |
Why?
| DNA Topoisomerases, Type I | 1 | 1987 | 14 | 0.020 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 45 | 0.020 |
Why?
| Angiogenesis Inhibitors | 1 | 2008 | 220 | 0.020 |
Why?
| Fluorescence | 1 | 2007 | 160 | 0.020 |
Why?
| Mice, Nude | 1 | 2008 | 683 | 0.020 |
Why?
| Biological Assay | 1 | 2007 | 118 | 0.020 |
Why?
| Capsules | 1 | 2006 | 40 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2007 | 376 | 0.020 |
Why?
| Antigens, Viral | 1 | 2007 | 178 | 0.020 |
Why?
| Species Specificity | 1 | 1988 | 575 | 0.020 |
Why?
| Blotting, Northern | 2 | 1998 | 200 | 0.020 |
Why?
| Solubility | 1 | 2006 | 235 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2009 | 1245 | 0.020 |
Why?
| Glutathione | 1 | 1988 | 348 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2008 | 530 | 0.020 |
Why?
| Plant Leaves | 1 | 2007 | 139 | 0.020 |
Why?
| Caspases | 1 | 2007 | 245 | 0.020 |
Why?
| Amphotericin B | 1 | 2005 | 29 | 0.020 |
Why?
| Cell Death | 1 | 2007 | 354 | 0.020 |
Why?
| Plant Components, Aerial | 1 | 2005 | 3 | 0.020 |
Why?
| Microtubule-Associated Proteins | 1 | 2007 | 192 | 0.020 |
Why?
| Biological Transport | 1 | 2006 | 401 | 0.020 |
Why?
| Drosophila | 1 | 1987 | 143 | 0.020 |
Why?
| Culture | 1 | 2006 | 124 | 0.020 |
Why?
| Telephone | 1 | 2006 | 167 | 0.020 |
Why?
| Social Work | 1 | 2006 | 83 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 958 | 0.010 |
Why?
| Double-Blind Method | 1 | 2010 | 1876 | 0.010 |
Why?
| Pilot Projects | 1 | 2010 | 1587 | 0.010 |
Why?
| Coumarins | 1 | 2004 | 21 | 0.010 |
Why?
| Cognition Disorders | 1 | 2009 | 505 | 0.010 |
Why?
| Flow Cytometry | 1 | 2008 | 1156 | 0.010 |
Why?
| Fluorouracil | 1 | 2004 | 199 | 0.010 |
Why?
| Chemotherapy, Adjuvant | 1 | 2004 | 381 | 0.010 |
Why?
| Methotrexate | 1 | 2004 | 249 | 0.010 |
Why?
| Models, Molecular | 1 | 2008 | 1492 | 0.010 |
Why?
| Poverty | 1 | 2006 | 496 | 0.010 |
Why?
| Social Support | 1 | 2006 | 588 | 0.010 |
Why?
| 14-3-3 Proteins | 1 | 2000 | 17 | 0.010 |
Why?
| Cations | 1 | 2000 | 80 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2007 | 3083 | 0.010 |
Why?
| Colorectal Neoplasms | 1 | 2006 | 752 | 0.010 |
Why?
| Ethacrynic Acid | 1 | 1998 | 1 | 0.010 |
Why?
| Absorption | 1 | 1998 | 58 | 0.010 |
Why?
| Chemistry, Pharmaceutical | 1 | 1998 | 107 | 0.010 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 1052 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1998 | 205 | 0.010 |
Why?
| Brain Neoplasms | 1 | 2006 | 1171 | 0.010 |
Why?
| Immune Sera | 1 | 1997 | 86 | 0.010 |
Why?
| Oxidants | 1 | 1997 | 109 | 0.010 |
Why?
| Immunoblotting | 1 | 1997 | 305 | 0.010 |
Why?
| Osteomyelitis | 1 | 1998 | 122 | 0.010 |
Why?
| Adult | 1 | 1999 | 35576 | 0.010 |
Why?
| Infant | 1 | 2010 | 9024 | 0.010 |
Why?
| Rabbits | 1 | 1997 | 778 | 0.010 |
Why?
| Child, Preschool | 1 | 2010 | 10517 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2006 | 7086 | 0.010 |
Why?
| Growth Substances | 1 | 1994 | 152 | 0.010 |
Why?
| Lung Neoplasms | 1 | 2006 | 2344 | 0.010 |
Why?
| Activating Transcription Factors | 1 | 1993 | 2 | 0.010 |
Why?
| Epithelium | 1 | 1994 | 311 | 0.010 |
Why?
| Baculoviridae | 1 | 1992 | 44 | 0.010 |
Why?
| Zinc Fingers | 1 | 1992 | 44 | 0.010 |
Why?
| Moths | 1 | 1992 | 39 | 0.010 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1992 | 181 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 1997 | 2406 | 0.010 |
Why?
| Swine | 1 | 1994 | 760 | 0.010 |
Why?
| Genetic Vectors | 1 | 1992 | 312 | 0.010 |
Why?
| Adolescent | 1 | 2010 | 20393 | 0.010 |
Why?
| Child | 1 | 2010 | 20883 | 0.010 |
Why?
| Protein Processing, Post-Translational | 1 | 1992 | 455 | 0.010 |
Why?
| Zinc | 1 | 1993 | 294 | 0.010 |
Why?
| Epithelial Cells | 1 | 1994 | 1065 | 0.000 |
Why?
| Aged | 1 | 2006 | 22103 | 0.000 |
Why?
| Middle Aged | 1 | 2006 | 31154 | 0.000 |
Why?
| Mutation | 1 | 1993 | 3717 | 0.000 |
Why?
|
|
Kroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|